Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Daniel S. Bandari"'
Autor:
Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Emily McCusker, Joan Largent, Aleksej Zuzek, Alberto Esquenazi
Publikováno v:
Toxicon: X, Vol 7, Iss , Pp 100040- (2020)
Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity In
Externí odkaz:
https://doaj.org/article/d5c3181fa04645848812ae2c272c4d98
Autor:
Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Aubrey Manack Adams, Joan Largent, Alberto Esquenazi
Publikováno v:
Journal of Rehabilitation Medicine, Vol 49, Iss 8, Pp 659-666 (2017)
Objective: The main aim of this study was to determine the utilization patterns and effectiveness of onabotulinumtoxinA (Botox®) for treatment of spasticity in clinical practice. Design: An international, multicentre, prospective, observational stud
Externí odkaz:
https://doaj.org/article/1b4fd426e5904af4961723a7ed7e0266
Autor:
Wolfgang H. Jost, Aleksej Zuzek, Joan Largent, Daniel S. Bandari, Simon F. T. Tang, Ganesh Bavikatte, Aubrey Manack Adams, Michael C. Munin, Alberto Esquenazi, Gerard E. Francisco
Publikováno v:
Pm & R
Introduction OnabotulinumtoxinA treatment for spasticity varies according to numerous factors and is individualized to meet treatment goals. Objective Explore real-world onabotulinumtoxinA utilization and effectiveness in patients with lower limb spa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001fed6b8e292f982956df0389c6f4b9
https://doi.org/10.1002/pmrj.12517
https://doi.org/10.1002/pmrj.12517
Autor:
Joan Largent, Aleksej Zuzek, Gerard E. Francisco, Wolfgang H. Jost, Simon F. T. Tang, Daniel S. Bandari, Aubrey Manack Adams, Alberto Esquenazi, Michael C. Munin, Ganesh Bavikatte
Publikováno v:
Pm & R
Introduction OnabotulinumtoxinA treatment for spasticity is dependent on numerous factors and varies according to selected treatment goals. Objective To examine real-world onabotulinumtoxinA treatment utilization and effectiveness in patients with up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ccb10c84c7cef71596e0595e2abe78
http://europepmc.org/articles/PMC7687094
http://europepmc.org/articles/PMC7687094
Autor:
Daniel S. Bandari, Angeli Mayadev, Mohamed Sakel, Alberto Esquenazi, Aleksej Zuzek, Joan Largent, Gerard E. Francisco
Publikováno v:
Toxicon. 214:S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7893f4e2b5dafba8bc1aacf62f99b0ce
https://doi.org/10.1016/j.toxicon.2021.11.022
https://doi.org/10.1016/j.toxicon.2021.11.022
Autor:
Alberto Esquenazi, Wuwei Feng, George F. Wittenberg, Philippe Gallien, Alessio Baricich, Kristina Fanning, Aleksej Zuzek, Gerard E. Francisco, Daniel S. Bandari
Publikováno v:
Toxicon. 214:S17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::771fca77d4aed657daa8720f4eb3db2d
https://doi.org/10.1016/j.toxicon.2021.11.047
https://doi.org/10.1016/j.toxicon.2021.11.047
Autor:
Alberto Esquenazi, Daniel S. Bandari, Aleksej Zuzek, Gerard E. Francisco, Emily McCusker, Ganesh Bavikatte, Wolfgang H. Jost, Joan Largent
Publikováno v:
Toxicon: X
Toxicon: X, Vol 7, Iss, Pp 100040-(2020)
Toxicon: X, Vol 7, Iss, Pp 100040-(2020)
Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233dc08141484f2c6aed050fc41d89bd
http://europepmc.org/articles/PMC7452133
http://europepmc.org/articles/PMC7452133
Autor:
Alessio Baricich, Kristina Fanning, Daniel S. Bandari, Wuwei Feng, Gerard E. Francisco, George F. Wittenberg, Philippe Gallien, Aleksej Zuzek, Alberto Esquenazi
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 102:2172-2184.e6
Objective To identify baseline characteristics and treatment-related variables that affect adherence to onabotulinumtoxinA treatment from the Adult Spasticity International Registry (ASPIRE) study. Design Prospective, observational registry (NCT01930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fee8d0219368397d8869678538401b81
https://doi.org/10.1016/j.apmr.2021.06.008
https://doi.org/10.1016/j.apmr.2021.06.008
Autor:
Wuwei Feng, Kristina Fanning, Daniel S. Bandari, Aleksej Zuzek, Alberto Esquenazi, Gerard E. Francisco, George F. Wittenberg, Alessio Baricich, Philippe Gallien
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 102:e48
Research Objectives To examine the relationship between real-world dosing and treatment intervals of onabotulinumtoxinA for adult spasticity Design Post hoc analysis of data collected from the prospective, observational, international Adult Spasticit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7d6815d7f403e232ac434c66c532cfc
https://doi.org/10.1016/j.apmr.2021.07.605
https://doi.org/10.1016/j.apmr.2021.07.605
Autor:
Joan Largent, Ganesh Bavikatte, Daniel S. Bandari, Gerard E. Francisco, Wolfgang H. Jost, Alberto Esquenazi, Aubrey Manack Adams
Publikováno v:
Journal of Rehabilitation Medicine, Vol 49, Iss 8, Pp 659-666 (2017)
Objective: The main aim of this study was to determine the utilization patterns and effectiveness of onabotulinumtoxinA (Botox®) for treatment of spasticity in clinical practice. Design: An international, multicentre, prospective, observational stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3f7268994a60e13c554a4ff8ad7861
https://doi.org/10.2340/16501977-2245
https://doi.org/10.2340/16501977-2245